Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.52987221 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.52987221 |
3 | L-phenylalanine metabolic process (GO:0006558) | 7.14324040 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.14324040 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 7.00460807 |
6 | indole-containing compound catabolic process (GO:0042436) | 6.62396211 |
7 | indolalkylamine catabolic process (GO:0046218) | 6.62396211 |
8 | tryptophan catabolic process (GO:0006569) | 6.62396211 |
9 | kynurenine metabolic process (GO:0070189) | 6.41943864 |
10 | tryptophan metabolic process (GO:0006568) | 6.21103344 |
11 | bile acid biosynthetic process (GO:0006699) | 6.13864387 |
12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.11662191 |
13 | alpha-linolenic acid metabolic process (GO:0036109) | 5.79414812 |
14 | glyoxylate metabolic process (GO:0046487) | 5.78163618 |
15 | urea metabolic process (GO:0019627) | 5.67558434 |
16 | urea cycle (GO:0000050) | 5.67558434 |
17 | flavonoid metabolic process (GO:0009812) | 5.53065470 |
18 | regulation of protein activation cascade (GO:2000257) | 5.52041849 |
19 | complement activation, alternative pathway (GO:0006957) | 5.48505228 |
20 | negative regulation of fibrinolysis (GO:0051918) | 5.48334592 |
21 | regulation of fibrinolysis (GO:0051917) | 5.40597771 |
22 | protein carboxylation (GO:0018214) | 5.37865089 |
23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.37865089 |
24 | high-density lipoprotein particle remodeling (GO:0034375) | 5.32839203 |
25 | bile acid metabolic process (GO:0008206) | 5.21917259 |
26 | nitrogen cycle metabolic process (GO:0071941) | 5.21507805 |
27 | regulation of complement activation (GO:0030449) | 5.15486635 |
28 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.13434886 |
29 | aromatic amino acid family metabolic process (GO:0009072) | 5.05070420 |
30 | sulfur amino acid catabolic process (GO:0000098) | 5.03155089 |
31 | cysteine metabolic process (GO:0006534) | 5.02365752 |
32 | serine family amino acid catabolic process (GO:0009071) | 4.95729513 |
33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.95580161 |
34 | coenzyme catabolic process (GO:0009109) | 4.92723822 |
35 | homocysteine metabolic process (GO:0050667) | 4.83432530 |
36 | indolalkylamine metabolic process (GO:0006586) | 4.70073644 |
37 | reverse cholesterol transport (GO:0043691) | 4.69328828 |
38 | regulation of triglyceride catabolic process (GO:0010896) | 4.66658021 |
39 | epoxygenase P450 pathway (GO:0019373) | 4.65898052 |
40 | cellular biogenic amine catabolic process (GO:0042402) | 4.64198682 |
41 | amine catabolic process (GO:0009310) | 4.64198682 |
42 | alpha-amino acid catabolic process (GO:1901606) | 4.62616179 |
43 | triglyceride homeostasis (GO:0070328) | 4.62065776 |
44 | acylglycerol homeostasis (GO:0055090) | 4.62065776 |
45 | protein-lipid complex remodeling (GO:0034368) | 4.61808330 |
46 | macromolecular complex remodeling (GO:0034367) | 4.61808330 |
47 | plasma lipoprotein particle remodeling (GO:0034369) | 4.61808330 |
48 | tyrosine metabolic process (GO:0006570) | 4.59109763 |
49 | regulation of cholesterol esterification (GO:0010872) | 4.57168938 |
50 | regulation of plasminogen activation (GO:0010755) | 4.53217523 |
51 | bile acid and bile salt transport (GO:0015721) | 4.52194978 |
52 | phospholipid efflux (GO:0033700) | 4.49570429 |
53 | amino-acid betaine metabolic process (GO:0006577) | 4.46042420 |
54 | proline metabolic process (GO:0006560) | 4.45971241 |
55 | lysine metabolic process (GO:0006553) | 4.45832247 |
56 | lysine catabolic process (GO:0006554) | 4.45832247 |
57 | nucleobase catabolic process (GO:0046113) | 4.42367344 |
58 | imidazole-containing compound metabolic process (GO:0052803) | 4.38598312 |
59 | drug metabolic process (GO:0017144) | 4.38208828 |
60 | cellular ketone body metabolic process (GO:0046950) | 4.37328232 |
61 | negative regulation of sterol transport (GO:0032372) | 4.34105654 |
62 | negative regulation of cholesterol transport (GO:0032375) | 4.34105654 |
63 | omega-hydroxylase P450 pathway (GO:0097267) | 4.28777477 |
64 | glycine metabolic process (GO:0006544) | 4.26806111 |
65 | cellular glucuronidation (GO:0052695) | 4.26695958 |
66 | cellular amino acid catabolic process (GO:0009063) | 4.22381816 |
67 | benzene-containing compound metabolic process (GO:0042537) | 4.16276900 |
68 | plasma lipoprotein particle clearance (GO:0034381) | 4.16168898 |
69 | glutamate metabolic process (GO:0006536) | 4.13756229 |
70 | regulation of bile acid biosynthetic process (GO:0070857) | 4.11497560 |
71 | ethanol oxidation (GO:0006069) | 4.08918064 |
72 | cellular modified amino acid catabolic process (GO:0042219) | 4.08471491 |
73 | cholesterol efflux (GO:0033344) | 4.07714266 |
74 | fibrinolysis (GO:0042730) | 4.06143008 |
75 | drug catabolic process (GO:0042737) | 4.03061117 |
76 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.01293687 |
77 | serine family amino acid metabolic process (GO:0009069) | 3.98373411 |
78 | cofactor catabolic process (GO:0051187) | 3.96645827 |
79 | arginine metabolic process (GO:0006525) | 3.95196441 |
80 | intestinal absorption (GO:0050892) | 3.90575132 |
81 | blood coagulation, intrinsic pathway (GO:0007597) | 3.89219916 |
82 | complement activation, classical pathway (GO:0006958) | 3.87307492 |
83 | acetyl-CoA metabolic process (GO:0006084) | 3.86195696 |
84 | cytolysis (GO:0019835) | 3.84481388 |
85 | plasma lipoprotein particle assembly (GO:0034377) | 3.84322607 |
86 | low-density lipoprotein particle remodeling (GO:0034374) | 3.83956124 |
87 | aldehyde catabolic process (GO:0046185) | 3.81671155 |
88 | phospholipid homeostasis (GO:0055091) | 3.80150601 |
89 | glucuronate metabolic process (GO:0019585) | 3.79540221 |
90 | uronic acid metabolic process (GO:0006063) | 3.79540221 |
91 | complement activation (GO:0006956) | 3.77492428 |
92 | ketone body metabolic process (GO:1902224) | 3.77153540 |
93 | protein activation cascade (GO:0072376) | 3.76995486 |
94 | serine family amino acid biosynthetic process (GO:0009070) | 3.74201641 |
95 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.69731824 |
96 | organic acid catabolic process (GO:0016054) | 3.69429132 |
97 | carboxylic acid catabolic process (GO:0046395) | 3.69429132 |
98 | positive regulation of lipid catabolic process (GO:0050996) | 3.67069103 |
99 | cholesterol homeostasis (GO:0042632) | 3.66746025 |
100 | intestinal cholesterol absorption (GO:0030299) | 3.66522557 |
101 | NAD biosynthetic process (GO:0009435) | 3.65493545 |
102 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.65129146 |
103 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.65129146 |
104 | negative regulation of lipase activity (GO:0060192) | 3.64901308 |
105 | regulation of cholesterol homeostasis (GO:2000188) | 3.64054413 |
106 | sterol homeostasis (GO:0055092) | 3.60601923 |
107 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.57540184 |
108 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.57540184 |
109 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.53427027 |
110 | exogenous drug catabolic process (GO:0042738) | 3.51677784 |
111 | oxidative demethylation (GO:0070989) | 3.50240465 |
112 | plasma lipoprotein particle organization (GO:0071827) | 3.38964854 |
113 | negative regulation of digestive system process (GO:0060457) | 3.35803613 |
114 | positive regulation of hormone metabolic process (GO:0032352) | 3.25855889 |
115 | phenylpropanoid metabolic process (GO:0009698) | 3.22436595 |
116 | alkaloid metabolic process (GO:0009820) | 3.16485735 |
117 | protein-lipid complex subunit organization (GO:0071825) | 3.11614762 |
118 | behavioral response to nicotine (GO:0035095) | 3.10748994 |
119 | negative regulation of blood coagulation (GO:0030195) | 3.09507626 |
120 | negative regulation of hemostasis (GO:1900047) | 3.09507626 |
121 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.07168472 |
122 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.07141986 |
123 | glutamine family amino acid catabolic process (GO:0009065) | 3.06743129 |
124 | arginine catabolic process (GO:0006527) | 3.06135936 |
125 | sodium-independent organic anion transport (GO:0043252) | 3.05393787 |
126 | peptidyl-glutamic acid modification (GO:0018200) | 3.04481458 |
127 | acute-phase response (GO:0006953) | 3.02586258 |
128 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.02458337 |
129 | protein-lipid complex assembly (GO:0065005) | 3.01770908 |
130 | neurofilament cytoskeleton organization (GO:0060052) | 2.98776104 |
131 | sterol transport (GO:0015918) | 2.96851269 |
132 | cholesterol transport (GO:0030301) | 2.96851269 |
133 | S-adenosylmethionine metabolic process (GO:0046500) | 2.95046349 |
134 | response to misfolded protein (GO:0051788) | 2.94116733 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.08346781 |
2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.01213778 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.89042607 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.38946117 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.37430920 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.70311703 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.19080351 |
8 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.09774788 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.05882912 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.58282848 |
11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.85072908 |
12 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.29913635 |
13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.09517895 |
14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.4377286 |
15 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.95138096 |
16 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.93227613 |
17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.90438381 |
18 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.86212705 |
19 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.79339959 |
20 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.77121792 |
21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.75099812 |
22 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.73027177 |
23 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.67579632 |
24 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.67546611 |
25 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.64382918 |
26 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.63346003 |
27 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62959817 |
28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.62742549 |
29 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.59779427 |
30 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.59403661 |
31 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.56809251 |
32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.56735172 |
33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.50389167 |
34 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.50353508 |
35 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49772242 |
36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.46077588 |
37 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.45471787 |
38 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.45137002 |
39 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.43143356 |
40 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.38008906 |
41 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.37815250 |
42 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.32648366 |
43 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.31760169 |
44 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.30413254 |
45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.29267084 |
46 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.27814703 |
47 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.27505740 |
48 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.27497469 |
49 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.27497469 |
50 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.26551256 |
51 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.19304929 |
52 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.14964776 |
53 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.14442076 |
54 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14442076 |
55 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.12669788 |
56 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.12240688 |
57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.10949070 |
58 | GATA1_22025678_ChIP-Seq_K562_Human | 1.10899144 |
59 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.10857163 |
60 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.10507532 |
61 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.08455439 |
62 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.08172824 |
63 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.07796779 |
64 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.06990999 |
65 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.05888886 |
66 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.05752580 |
67 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.04961029 |
68 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03878049 |
69 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.00116595 |
70 | VDR_22108803_ChIP-Seq_LS180_Human | 0.99884179 |
71 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95064059 |
72 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.94092090 |
73 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.93720043 |
74 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.93094969 |
75 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.92932225 |
76 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.92774131 |
77 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.92674181 |
78 | * AR_19668381_ChIP-Seq_PC3_Human | 0.91227936 |
79 | * POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.90886018 |
80 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90520613 |
81 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.88960399 |
82 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88916234 |
83 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.88837615 |
84 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.87980449 |
85 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86712967 |
86 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.86624692 |
87 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.86545605 |
88 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.86515516 |
89 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.86261311 |
90 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.85379396 |
91 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.84611775 |
92 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.84468530 |
93 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83713853 |
94 | ERA_21632823_ChIP-Seq_H3396_Human | 0.81350204 |
95 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.80515229 |
96 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.79624605 |
97 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79387740 |
98 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.77743522 |
99 | STAT3_23295773_ChIP-Seq_U87_Human | 0.77299901 |
100 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.76788166 |
101 | P300_19829295_ChIP-Seq_ESCs_Human | 0.76361217 |
102 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76014874 |
103 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.75670867 |
104 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75049772 |
105 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75049772 |
106 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.74918655 |
107 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.74454992 |
108 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.73643833 |
109 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.73603789 |
110 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.73555145 |
111 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71778017 |
112 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71316860 |
113 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70648614 |
114 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.70009940 |
115 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.69053964 |
116 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.68171972 |
117 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.64626161 |
118 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.63959575 |
119 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.63626823 |
120 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.63506813 |
121 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.62219849 |
122 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.61795568 |
123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.61344147 |
124 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.61113170 |
125 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.61043795 |
126 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.60467083 |
127 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.60460395 |
128 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.60446003 |
129 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.60311782 |
130 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.58200121 |
131 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.57907161 |
132 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.57746652 |
133 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.57450522 |
134 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.57328787 |
135 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.56568567 |
136 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.55965993 |
137 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.55550269 |
138 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.55510358 |
139 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.55482365 |
140 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.55410478 |
141 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.55329189 |
142 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.54261042 |
143 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53114427 |
144 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.52833814 |
145 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.52178462 |
146 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51594293 |
147 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.50496457 |
148 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.50470144 |
149 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50171729 |
150 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.49526849 |
151 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.49375373 |
152 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.49061051 |
153 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.48935349 |
154 | AR_20517297_ChIP-Seq_VCAP_Human | 0.48267790 |
155 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.47930522 |
156 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.46436580 |
157 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.45567583 |
158 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.44838778 |
159 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.44559322 |
160 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.44434963 |
161 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.43699301 |
162 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.43014214 |
163 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.42408388 |
164 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42207128 |
165 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.42140882 |
166 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.41672768 |
167 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.40165597 |
168 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.39789248 |
169 | * STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39632868 |
170 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.39431599 |
171 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38621049 |
172 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.38397541 |
173 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.37626913 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.54639456 |
2 | MP0005360_urolithiasis | 7.21791513 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.70541356 |
4 | MP0005365_abnormal_bile_salt | 6.53291553 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.94966003 |
6 | MP0003252_abnormal_bile_duct | 4.29577317 |
7 | MP0003806_abnormal_nucleotide_metabolis | 3.83027368 |
8 | MP0010329_abnormal_lipoprotein_level | 3.59946238 |
9 | MP0001666_abnormal_nutrient_absorption | 2.97401141 |
10 | MP0002138_abnormal_hepatobiliary_system | 2.82111474 |
11 | * MP0005083_abnormal_biliary_tract | 2.79108232 |
12 | MP0003195_calcinosis | 2.69857430 |
13 | MP0009840_abnormal_foam_cell | 2.63447938 |
14 | MP0005332_abnormal_amino_acid | 2.58540415 |
15 | MP0003868_abnormal_feces_composition | 2.38672348 |
16 | MP0003122_maternal_imprinting | 2.38546362 |
17 | MP0004019_abnormal_vitamin_homeostasis | 2.20461860 |
18 | MP0002118_abnormal_lipid_homeostasis | 2.11051294 |
19 | * MP0000609_abnormal_liver_physiology | 2.10284726 |
20 | MP0003191_abnormal_cellular_cholesterol | 1.99332217 |
21 | MP0010386_abnormal_urinary_bladder | 1.70074399 |
22 | MP0005319_abnormal_enzyme/_coenzyme | 1.68313851 |
23 | MP0006276_abnormal_autonomic_nervous | 1.61918558 |
24 | MP0003880_abnormal_central_pattern | 1.57316416 |
25 | MP0009697_abnormal_copulation | 1.57228958 |
26 | MP0002909_abnormal_adrenal_gland | 1.57037991 |
27 | MP0002089_abnormal_postnatal_growth/wei | 1.55196140 |
28 | MP0005451_abnormal_body_composition | 1.54820214 |
29 | MP0004133_heterotaxia | 1.51357668 |
30 | MP0001764_abnormal_homeostasis | 1.49361835 |
31 | MP0003879_abnormal_hair_cell | 1.49342135 |
32 | MP0003011_delayed_dark_adaptation | 1.47040277 |
33 | MP0000778_abnormal_nervous_system | 1.46369903 |
34 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.35378773 |
35 | MP0002653_abnormal_ependyma_morphology | 1.27079761 |
36 | MP0004270_analgesia | 1.24576436 |
37 | MP0005647_abnormal_sex_gland | 1.19376659 |
38 | MP0002160_abnormal_reproductive_system | 1.19110842 |
39 | MP0004742_abnormal_vestibular_system | 1.18666049 |
40 | MP0002557_abnormal_social/conspecific_i | 1.18158507 |
41 | MP0005551_abnormal_eye_electrophysiolog | 1.14712168 |
42 | MP0003121_genomic_imprinting | 1.10206992 |
43 | MP0009643_abnormal_urine_homeostasis | 1.10087417 |
44 | MP0009764_decreased_sensitivity_to | 1.10043714 |
45 | * MP0000598_abnormal_liver_morphology | 1.09534319 |
46 | MP0005167_abnormal_blood-brain_barrier | 1.06959390 |
47 | MP0003656_abnormal_erythrocyte_physiolo | 1.05415224 |
48 | MP0001984_abnormal_olfaction | 1.03506867 |
49 | * MP0005220_abnormal_exocrine_pancreas | 1.03323431 |
50 | MP0000955_abnormal_spinal_cord | 1.02468968 |
51 | MP0003787_abnormal_imprinting | 1.02397211 |
52 | MP0001529_abnormal_vocalization | 1.02291902 |
53 | MP0002254_reproductive_system_inflammat | 1.01716390 |
54 | MP0003705_abnormal_hypodermis_morpholog | 1.01562974 |
55 | MP0003186_abnormal_redox_activity | 1.00687734 |
56 | MP0010368_abnormal_lymphatic_system | 0.97895370 |
57 | MP0009763_increased_sensitivity_to | 0.96825482 |
58 | MP0005499_abnormal_olfactory_system | 0.96619182 |
59 | MP0005394_taste/olfaction_phenotype | 0.96619182 |
60 | MP0005423_abnormal_somatic_nervous | 0.93967770 |
61 | MP0002735_abnormal_chemical_nociception | 0.91974613 |
62 | MP0003119_abnormal_digestive_system | 0.91304670 |
63 | MP0003635_abnormal_synaptic_transmissio | 0.89441712 |
64 | MP0002184_abnormal_innervation | 0.88316608 |
65 | MP0009745_abnormal_behavioral_response | 0.87550271 |
66 | * MP0005084_abnormal_gallbladder_morpholo | 0.87431399 |
67 | MP0002876_abnormal_thyroid_physiology | 0.86770742 |
68 | MP0000604_amyloidosis | 0.86643184 |
69 | MP0001485_abnormal_pinna_reflex | 0.84964287 |
70 | MP0002064_seizures | 0.84576288 |
71 | MP0005636_abnormal_mineral_homeostasis | 0.84261316 |
72 | MP0001486_abnormal_startle_reflex | 0.84124045 |
73 | MP0002272_abnormal_nervous_system | 0.83087573 |
74 | * MP0009642_abnormal_blood_homeostasis | 0.81779697 |
75 | MP0002882_abnormal_neuron_morphology | 0.81572234 |
76 | MP0003123_paternal_imprinting | 0.81382397 |
77 | MP0009046_muscle_twitch | 0.81249038 |
78 | MP0002572_abnormal_emotion/affect_behav | 0.80809495 |
79 | MP0008469_abnormal_protein_level | 0.80414667 |
80 | MP0002752_abnormal_somatic_nervous | 0.80147860 |
81 | MP0002063_abnormal_learning/memory/cond | 0.79897279 |
82 | MP0003567_abnormal_fetal_cardiomyocyte | 0.78340868 |
83 | * MP0002078_abnormal_glucose_homeostasis | 0.78147376 |
84 | MP0009765_abnormal_xenobiotic_induced | 0.77379623 |
85 | MP0003890_abnormal_embryonic-extraembry | 0.77056051 |
86 | MP0001440_abnormal_grooming_behavior | 0.73971806 |
87 | MP0005187_abnormal_penis_morphology | 0.73787712 |
88 | MP0005408_hypopigmentation | 0.73760453 |
89 | MP0005334_abnormal_fat_pad | 0.73707153 |
90 | MP0003183_abnormal_peptide_metabolism | 0.72722089 |
91 | MP0003632_abnormal_nervous_system | 0.72585898 |
92 | MP0005377_hearing/vestibular/ear_phenot | 0.72411431 |
93 | MP0003878_abnormal_ear_physiology | 0.72411431 |
94 | MP0002734_abnormal_mechanical_nocicepti | 0.71740986 |
95 | MP0006292_abnormal_olfactory_placode | 0.71340302 |
96 | * MP0002928_abnormal_bile_duct | 0.70821592 |
97 | MP0000579_abnormal_nail_morphology | 0.70476109 |
98 | MP0002067_abnormal_sensory_capabilities | 0.70127538 |
99 | MP0005376_homeostasis/metabolism_phenot | 0.70113564 |
100 | MP0002069_abnormal_eating/drinking_beha | 0.69873726 |
101 | MP0009379_abnormal_foot_pigmentation | 0.69867348 |
102 | MP0001188_hyperpigmentation | 0.69084052 |
103 | MP0009384_cardiac_valve_regurgitation | 0.68851810 |
104 | MP0003631_nervous_system_phenotype | 0.67459970 |
105 | MP0005448_abnormal_energy_balance | 0.66155890 |
106 | MP0004381_abnormal_hair_follicle | 0.66061820 |
107 | MP0005645_abnormal_hypothalamus_physiol | 0.65244563 |
108 | MP0002971_abnormal_brown_adipose | 0.64936676 |
109 | MP0002229_neurodegeneration | 0.64314673 |
110 | MP0005535_abnormal_body_temperature | 0.64066021 |
111 | MP0005670_abnormal_white_adipose | 0.63593508 |
112 | MP0004811_abnormal_neuron_physiology | 0.63555587 |
113 | MP0005195_abnormal_posterior_eye | 0.63522557 |
114 | MP0004142_abnormal_muscle_tone | 0.63057400 |
115 | MP0002152_abnormal_brain_morphology | 0.62693851 |
116 | MP0003633_abnormal_nervous_system | 0.62058288 |
117 | MP0006036_abnormal_mitochondrial_physio | 0.61343190 |
118 | MP0009053_abnormal_anal_canal | 0.58168161 |
119 | MP0000639_abnormal_adrenal_gland | 0.57052574 |
120 | MP0004130_abnormal_muscle_cell | 0.56782204 |
121 | MP0005395_other_phenotype | 0.52676996 |
122 | MP0003690_abnormal_glial_cell | 0.52144851 |
123 | MP0000566_synostosis | 0.51783505 |
124 | MP0001661_extended_life_span | 0.50400058 |
125 | MP0001756_abnormal_urination | 0.50222889 |
126 | MP0004782_abnormal_surfactant_physiolog | 0.50055419 |
127 | MP0005266_abnormal_metabolism | 0.49363376 |
128 | MP0006035_abnormal_mitochondrial_morpho | 0.47977968 |
129 | MP0003724_increased_susceptibility_to | 0.47220591 |
130 | MP0003638_abnormal_response/metabolism_ | 0.47041069 |
131 | MP0005248_abnormal_Harderian_gland | 0.46355398 |
132 | MP0009672_abnormal_birth_weight | 0.45412806 |
133 | MP0003329_amyloid_beta_deposits | 0.45166499 |
134 | MP0002168_other_aberrant_phenotype | 0.42632205 |
135 | * MP0003953_abnormal_hormone_level | 0.42478190 |
136 | MP0003718_maternal_effect | 0.41935158 |
137 | MP0002822_catalepsy | 0.41573304 |
138 | MP0002796_impaired_skin_barrier | 0.40985066 |
139 | MP0003959_abnormal_lean_body | 0.40346779 |
140 | MP0008874_decreased_physiological_sensi | 0.39530036 |
141 | MP0004883_abnormal_blood_vessel | 0.39367874 |
142 | MP0002136_abnormal_kidney_physiology | 0.38421111 |
143 | MP0005464_abnormal_platelet_physiology | 0.37456869 |
144 | MP0000427_abnormal_hair_cycle | 0.36043299 |
145 | MP0008872_abnormal_physiological_respon | 0.34882599 |
146 | * MP0001944_abnormal_pancreas_morphology | 0.34095501 |
147 | MP0003436_decreased_susceptibility_to | 0.33679243 |
148 | MP0005166_decreased_susceptibility_to | 0.32498244 |
149 | MP0008873_increased_physiological_sensi | 0.31333814 |
150 | MP0002060_abnormal_skin_morphology | 0.30543406 |
151 | MP0001881_abnormal_mammary_gland | 0.29852102 |
152 | MP0001324_abnormal_eye_pigmentation | 0.28087157 |
153 | MP0004264_abnormal_extraembryonic_tissu | 0.27721053 |
154 | MP0000230_abnormal_systemic_arterial | 0.27578284 |
155 | MP0001853_heart_inflammation | 0.26416299 |
156 | MP0001243_abnormal_dermal_layer | 0.26095352 |
157 | MP0003075_altered_response_to | 0.25945231 |
158 | MP0002970_abnormal_white_adipose | 0.25749795 |
159 | MP0005164_abnormal_response_to | 0.25733743 |
160 | MP0002090_abnormal_vision | 0.25685699 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 7.60879001 |
2 | Deep venous thrombosis (HP:0002625) | 7.42872981 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.26496940 |
4 | Prolonged partial thromboplastin time (HP:0003645) | 6.80049287 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.60237730 |
6 | Hypobetalipoproteinemia (HP:0003563) | 6.52612888 |
7 | Xanthomatosis (HP:0000991) | 6.13924744 |
8 | Complement deficiency (HP:0004431) | 5.81635571 |
9 | Hyperlipoproteinemia (HP:0010980) | 5.34971179 |
10 | Joint hemorrhage (HP:0005261) | 4.99741682 |
11 | Hypolipoproteinemia (HP:0010981) | 4.77796909 |
12 | Hyperglycinemia (HP:0002154) | 4.62603582 |
13 | Epidermoid cyst (HP:0200040) | 4.56708139 |
14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.53829602 |
15 | Fat malabsorption (HP:0002630) | 4.49235466 |
16 | Hyperammonemia (HP:0001987) | 4.43338498 |
17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.31764591 |
18 | Ketosis (HP:0001946) | 4.25688414 |
19 | Abnormality of methionine metabolism (HP:0010901) | 4.21069739 |
20 | Abnormality of complement system (HP:0005339) | 4.18359949 |
21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.16161180 |
22 | Hypoalphalipoproteinemia (HP:0003233) | 4.14089407 |
23 | Conjugated hyperbilirubinemia (HP:0002908) | 4.10322377 |
24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.06895827 |
25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.05503769 |
26 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.90775151 |
27 | Abnormality of glycine metabolism (HP:0010895) | 3.89910631 |
28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.89910631 |
29 | Hyperglycinuria (HP:0003108) | 3.87630846 |
30 | Hypoglycemic coma (HP:0001325) | 3.84521709 |
31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.76454074 |
32 | Hypercholesterolemia (HP:0003124) | 3.46552163 |
33 | Steatorrhea (HP:0002570) | 3.44394834 |
34 | Hyperbilirubinemia (HP:0002904) | 3.24941392 |
35 | Spontaneous abortion (HP:0005268) | 3.14920447 |
36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.13717149 |
37 | Abnormality of serum amino acid levels (HP:0003112) | 3.13059899 |
38 | Hypochromic microcytic anemia (HP:0004840) | 3.09822253 |
39 | Myocardial infarction (HP:0001658) | 3.08448976 |
40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07375321 |
41 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.04227494 |
42 | Hepatocellular carcinoma (HP:0001402) | 2.96784790 |
43 | Ketoacidosis (HP:0001993) | 2.96223558 |
44 | Myokymia (HP:0002411) | 2.91480564 |
45 | Delayed CNS myelination (HP:0002188) | 2.84128713 |
46 | Systemic lupus erythematosus (HP:0002725) | 2.83112806 |
47 | Hypoglycemic seizures (HP:0002173) | 2.78732172 |
48 | Skin nodule (HP:0200036) | 2.76977879 |
49 | Gout (HP:0001997) | 2.75107093 |
50 | Osteomalacia (HP:0002749) | 2.68143607 |
51 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.66557402 |
52 | Abnormality of purine metabolism (HP:0004352) | 2.65675406 |
53 | Metabolic acidosis (HP:0001942) | 2.65328578 |
54 | Progressive cerebellar ataxia (HP:0002073) | 2.64665904 |
55 | Acanthocytosis (HP:0001927) | 2.60718139 |
56 | Enlarged kidneys (HP:0000105) | 2.57727645 |
57 | Mitral stenosis (HP:0001718) | 2.57664279 |
58 | Genetic anticipation (HP:0003743) | 2.56230800 |
59 | Glomerulonephritis (HP:0000099) | 2.52765719 |
60 | Vascular calcification (HP:0004934) | 2.52505790 |
61 | Lethargy (HP:0001254) | 2.51454619 |
62 | Facial shape deformation (HP:0011334) | 2.48717399 |
63 | Potter facies (HP:0002009) | 2.48717399 |
64 | Neonatal onset (HP:0003623) | 2.47740422 |
65 | Esophageal varix (HP:0002040) | 2.42470932 |
66 | Cerebral edema (HP:0002181) | 2.39805945 |
67 | Abnormal urine phosphate concentration (HP:0012599) | 2.39224740 |
68 | Dicarboxylic aciduria (HP:0003215) | 2.37792763 |
69 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.37792763 |
70 | Spastic diplegia (HP:0001264) | 2.36091012 |
71 | Abnormal gallbladder morphology (HP:0012437) | 2.34059675 |
72 | Cortical dysplasia (HP:0002539) | 2.32752739 |
73 | Hyperphosphaturia (HP:0003109) | 2.29928410 |
74 | Cardiovascular calcification (HP:0011915) | 2.26831775 |
75 | Neoplasm of the liver (HP:0002896) | 2.26493505 |
76 | Late onset (HP:0003584) | 2.26234486 |
77 | Cholelithiasis (HP:0001081) | 2.26106223 |
78 | Irritability (HP:0000737) | 2.23756823 |
79 | Reticulocytosis (HP:0001923) | 2.23479920 |
80 | Gingival bleeding (HP:0000225) | 2.22290584 |
81 | Increased serum pyruvate (HP:0003542) | 2.22203517 |
82 | Abnormal gallbladder physiology (HP:0012438) | 2.22012425 |
83 | Cholecystitis (HP:0001082) | 2.22012425 |
84 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.21548609 |
85 | Menorrhagia (HP:0000132) | 2.19313140 |
86 | Amyloidosis (HP:0011034) | 2.18719599 |
87 | Pancreatitis (HP:0001733) | 2.14953899 |
88 | Malnutrition (HP:0004395) | 2.12614227 |
89 | Hypothermia (HP:0002045) | 2.12260481 |
90 | Thrombophlebitis (HP:0004418) | 2.11975856 |
91 | Brushfield spots (HP:0001088) | 2.10135029 |
92 | Proximal tubulopathy (HP:0000114) | 2.08056168 |
93 | Opisthotonus (HP:0002179) | 2.04833128 |
94 | Sensorimotor neuropathy (HP:0007141) | 2.04049217 |
95 | Abnormality of glycolysis (HP:0004366) | 2.02595764 |
96 | Bile duct proliferation (HP:0001408) | 2.01553231 |
97 | Abnormal biliary tract physiology (HP:0012439) | 2.01553231 |
98 | Abnormality of urine glucose concentration (HP:0011016) | 1.97777945 |
99 | Glycosuria (HP:0003076) | 1.97777945 |
100 | Hemorrhage of the eye (HP:0011885) | 1.96781912 |
101 | Hypophosphatemic rickets (HP:0004912) | 1.95904828 |
102 | Vomiting (HP:0002013) | 1.95782038 |
103 | Hyperglycemia (HP:0003074) | 1.95409157 |
104 | Rickets (HP:0002748) | 1.94001052 |
105 | Renal cortical cysts (HP:0000803) | 1.92814705 |
106 | Retinal atrophy (HP:0001105) | 1.91823885 |
107 | Drooling (HP:0002307) | 1.91807269 |
108 | Anosmia (HP:0000458) | 1.91517163 |
109 | Poikilocytosis (HP:0004447) | 1.91229062 |
110 | Abnormality of the intervertebral disk (HP:0005108) | 1.91021846 |
111 | Abnormality of the gallbladder (HP:0005264) | 1.90985439 |
112 | Symptomatic seizures (HP:0011145) | 1.90842470 |
113 | Agitation (HP:0000713) | 1.89457462 |
114 | Limb dystonia (HP:0002451) | 1.89065266 |
115 | Spastic tetraplegia (HP:0002510) | 1.88407297 |
116 | Cerebral palsy (HP:0100021) | 1.88319854 |
117 | Hepatoblastoma (HP:0002884) | 1.88172134 |
118 | Generalized aminoaciduria (HP:0002909) | 1.86869159 |
119 | Back pain (HP:0003418) | 1.86207698 |
120 | Status epilepticus (HP:0002133) | 1.86099303 |
121 | Hyperventilation (HP:0002883) | 1.82360844 |
122 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82302999 |
123 | Fair hair (HP:0002286) | 1.80072498 |
124 | Focal segmental glomerulosclerosis (HP:0000097) | 1.79986889 |
125 | Elevated hepatic transaminases (HP:0002910) | 1.79652894 |
126 | Hydroxyprolinuria (HP:0003080) | 1.78523967 |
127 | Abnormality of proline metabolism (HP:0010907) | 1.78523967 |
128 | Abnormality of iron homeostasis (HP:0011031) | 1.78358456 |
129 | Glomerulosclerosis (HP:0000096) | 1.78063186 |
130 | Arthropathy (HP:0003040) | 1.77398111 |
131 | Abnormal cartilage morphology (HP:0002763) | 1.75385182 |
132 | Type I diabetes mellitus (HP:0100651) | 1.74948577 |
133 | Abnormal pancreas size (HP:0012094) | 1.72307190 |
134 | Chorioretinal atrophy (HP:0000533) | 1.69938200 |
135 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.69932961 |
136 | Abnormality of alanine metabolism (HP:0010916) | 1.69932961 |
137 | Hyperalaninemia (HP:0003348) | 1.69932961 |
138 | Decreased central vision (HP:0007663) | 1.69691097 |
139 | Excessive salivation (HP:0003781) | 1.66815669 |
140 | Abnormality of the lower motor neuron (HP:0002366) | 1.66173517 |
141 | Focal seizures (HP:0007359) | 1.64108973 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.01190542 |
2 | SIK1 | 4.65849450 |
3 | FGFR4 | 4.57487808 |
4 | ERN1 | 3.98764232 |
5 | ERBB4 | 3.94871078 |
6 | INSRR | 3.64823727 |
7 | MARK1 | 3.62494017 |
8 | TAOK3 | 3.52304996 |
9 | MAP3K4 | 3.05761503 |
10 | MAP2K7 | 2.84932678 |
11 | BCR | 2.74179901 |
12 | CDK19 | 2.52880079 |
13 | MAP2K4 | 2.46620248 |
14 | NTRK3 | 2.42244473 |
15 | LATS1 | 2.39030465 |
16 | MST1R | 2.27667449 |
17 | PIK3CG | 1.95945999 |
18 | MAPK11 | 1.95759140 |
19 | DAPK2 | 1.93038753 |
20 | DYRK3 | 1.91351323 |
21 | FGFR2 | 1.88834220 |
22 | SIK2 | 1.88611106 |
23 | ADRBK2 | 1.65246167 |
24 | WNK4 | 1.61495539 |
25 | MINK1 | 1.56124445 |
26 | ERBB2 | 1.54931936 |
27 | PKN2 | 1.42343993 |
28 | PNCK | 1.34936898 |
29 | MAPK13 | 1.33935555 |
30 | ABL2 | 1.33864421 |
31 | OXSR1 | 1.28065141 |
32 | SRPK1 | 1.27168035 |
33 | PTK6 | 1.25079086 |
34 | FRK | 1.22134928 |
35 | STK38L | 1.20257823 |
36 | MAPK4 | 1.19251063 |
37 | TYK2 | 1.18308004 |
38 | PRKAA2 | 1.17969723 |
39 | NEK9 | 1.16429155 |
40 | JAK2 | 1.14416931 |
41 | FLT3 | 1.11161918 |
42 | TNIK | 1.09048953 |
43 | MAP3K7 | 1.08537992 |
44 | CAMKK2 | 1.03974928 |
45 | PAK3 | 1.00630622 |
46 | MAP4K2 | 1.00393530 |
47 | TYRO3 | 0.99956585 |
48 | DYRK1B | 0.99089457 |
49 | MAP3K14 | 0.97106606 |
50 | PKN1 | 0.96645002 |
51 | PRKCZ | 0.96129027 |
52 | NTRK1 | 0.92572241 |
53 | CAMK1D | 0.91030382 |
54 | DDR2 | 0.88934043 |
55 | CSNK1E | 0.88411353 |
56 | JAK1 | 0.87781021 |
57 | MAP3K6 | 0.86978073 |
58 | CDK5 | 0.86975179 |
59 | KDR | 0.86481769 |
60 | GRK1 | 0.84714317 |
61 | IRAK3 | 0.83891624 |
62 | MAPK15 | 0.81716525 |
63 | SGK2 | 0.80679818 |
64 | DYRK1A | 0.80199196 |
65 | MAPK12 | 0.80118104 |
66 | BMPR1B | 0.77583403 |
67 | TRIM28 | 0.75099809 |
68 | CAMK2G | 0.74936186 |
69 | PRKACG | 0.74482302 |
70 | MAP2K6 | 0.74015932 |
71 | EPHB2 | 0.73045482 |
72 | PIK3CA | 0.71713844 |
73 | MARK2 | 0.71344723 |
74 | GSK3A | 0.71203045 |
75 | PINK1 | 0.70316565 |
76 | PRKAA1 | 0.69175022 |
77 | TBK1 | 0.68642719 |
78 | SGK3 | 0.68329702 |
79 | EPHA3 | 0.67299832 |
80 | SGK223 | 0.67198112 |
81 | SGK494 | 0.67198112 |
82 | MAP3K11 | 0.66536576 |
83 | FGFR3 | 0.66365229 |
84 | CAMKK1 | 0.65547873 |
85 | PRKACA | 0.65286531 |
86 | TRIB3 | 0.62661817 |
87 | TAOK2 | 0.62048512 |
88 | STK16 | 0.60650307 |
89 | CDK18 | 0.60632854 |
90 | LATS2 | 0.60266261 |
91 | CDK15 | 0.59970682 |
92 | RPS6KA2 | 0.59625284 |
93 | CDK14 | 0.58668308 |
94 | PRKCE | 0.58453580 |
95 | CSNK1A1 | 0.57224679 |
96 | CSNK1G1 | 0.56627367 |
97 | STK24 | 0.55756716 |
98 | CDK11A | 0.54609661 |
99 | CAMK1G | 0.54214455 |
100 | MAP3K10 | 0.53494223 |
101 | CDK12 | 0.52680516 |
102 | PRKG1 | 0.50461576 |
103 | CAMK4 | 0.50259682 |
104 | MET | 0.49688021 |
105 | CSK | 0.49555640 |
106 | PHKG1 | 0.47741653 |
107 | PHKG2 | 0.47741653 |
108 | TIE1 | 0.47648426 |
109 | CAMK2A | 0.47421815 |
110 | IGF1R | 0.47369906 |
111 | TGFBR2 | 0.46132039 |
112 | IRAK2 | 0.45381112 |
113 | GRK6 | 0.45361652 |
114 | CASK | 0.45073990 |
115 | MAP3K1 | 0.44113725 |
116 | PRKCG | 0.43781908 |
117 | ICK | 0.43609868 |
118 | CSNK1A1L | 0.43531308 |
119 | RPS6KA3 | 0.42986541 |
120 | RIPK1 | 0.42957894 |
121 | MAPK7 | 0.42579757 |
122 | WNK3 | 0.42083726 |
123 | STK39 | 0.41784359 |
124 | EPHB1 | 0.40902784 |
125 | SGK1 | 0.39575669 |
126 | GSK3B | 0.39535210 |
127 | MAP3K5 | 0.39019382 |
128 | RET | 0.38861434 |
129 | MAP3K3 | 0.38707111 |
130 | ADRBK1 | 0.38574053 |
131 | CDK6 | 0.38273273 |
132 | PRKCQ | 0.37830338 |
133 | PTK2 | 0.37810287 |
134 | CAMK1 | 0.37649554 |
135 | PRKCB | 0.37592825 |
136 | CHUK | 0.36267677 |
137 | CSF1R | 0.35752989 |
138 | PASK | 0.35118393 |
139 | MAPK8 | 0.34788621 |
140 | MAP2K1 | 0.34562805 |
141 | MAPK9 | 0.33874793 |
142 | CSNK1D | 0.33526448 |
143 | CDK4 | 0.33053591 |
144 | DYRK2 | 0.31627270 |
145 | CSNK1G3 | 0.31175379 |
146 | CSNK1G2 | 0.30615853 |
147 | PRKCA | 0.28460165 |
148 | NTRK2 | 0.28094266 |
149 | EPHA4 | 0.28052320 |
150 | PRKACB | 0.28040209 |
151 | ABL1 | 0.27955661 |
152 | MTOR | 0.27881401 |
153 | FGFR1 | 0.27847515 |
154 | STK11 | 0.26896985 |
155 | EGFR | 0.26417045 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.68659827 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.50790696 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.29382332 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.29158272 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.98117760 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.83634707 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.80437499 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.72980697 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.56034731 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.49832473 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48164519 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36334602 |
13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.20947933 |
14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.19560494 |
15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14015929 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.12733164 |
17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.02305528 |
18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.92610696 |
19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89500496 |
20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88126296 |
21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86445927 |
22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.85988847 |
23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81635163 |
24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.80273171 |
25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.78805525 |
26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.72917131 |
27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71916518 |
28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.71615887 |
29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68682274 |
30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.64310699 |
31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.61585444 |
32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55446243 |
33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.51982397 |
34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49612408 |
35 | Bile secretion_Homo sapiens_hsa04976 | 1.46121173 |
36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.45501539 |
37 | * Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.38653097 |
38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.38620338 |
39 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.37511224 |
40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.36704827 |
41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.34853064 |
42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.29469225 |
43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29158398 |
44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.28640756 |
45 | ABC transporters_Homo sapiens_hsa02010 | 1.22365378 |
46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21199079 |
47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10963335 |
48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.10470877 |
49 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.05743219 |
50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.05064643 |
51 | Nicotine addiction_Homo sapiens_hsa05033 | 1.04798265 |
52 | Carbon metabolism_Homo sapiens_hsa01200 | 0.98919373 |
53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.93071535 |
54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92831552 |
55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90953806 |
56 | Lysine degradation_Homo sapiens_hsa00310 | 0.89434332 |
57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89424500 |
58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88969738 |
59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86937042 |
60 | GABAergic synapse_Homo sapiens_hsa04727 | 0.84411514 |
61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77732797 |
62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72227544 |
63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.67794172 |
64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.65665536 |
65 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.59209511 |
66 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57671506 |
67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55444212 |
68 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.50379006 |
69 | Phototransduction_Homo sapiens_hsa04744 | 0.49091499 |
70 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.48656901 |
71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.48304174 |
72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44290269 |
73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44195804 |
74 | Prion diseases_Homo sapiens_hsa05020 | 0.44181525 |
75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42996577 |
76 | Cocaine addiction_Homo sapiens_hsa05030 | 0.42751283 |
77 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.41308058 |
78 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37730160 |
79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35950932 |
80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.34149017 |
81 | Morphine addiction_Homo sapiens_hsa05032 | 0.33368632 |
82 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.32427915 |
83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30889497 |
84 | Axon guidance_Homo sapiens_hsa04360 | 0.29620829 |
85 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.28941247 |
86 | Taste transduction_Homo sapiens_hsa04742 | 0.27378359 |
87 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.26944209 |
88 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.25475670 |
89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23285651 |
90 | Parkinsons disease_Homo sapiens_hsa05012 | 0.23128618 |
91 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22906990 |
92 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.22603421 |
93 | Insulin resistance_Homo sapiens_hsa04931 | 0.21685861 |
94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20014437 |
95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18831641 |
96 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.17977434 |
97 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.17510368 |
98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15127563 |
99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12608835 |
100 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.12185477 |
101 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.11460573 |
102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.11343143 |
103 | Circadian entrainment_Homo sapiens_hsa04713 | 0.11172300 |
104 | Insulin secretion_Homo sapiens_hsa04911 | 0.11154225 |
105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.02178821 |
106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.00860325 |
107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00598233 |
108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2393208 |
109 | Amoebiasis_Homo sapiens_hsa05146 | -0.2392957 |
110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2391485 |
111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2390886 |
112 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.2145799 |
113 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.2143884 |
114 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2049981 |
115 | Bladder cancer_Homo sapiens_hsa05219 | -0.1978816 |
116 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1755187 |
117 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1702156 |
118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1553855 |
119 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1540563 |
120 | Hepatitis C_Homo sapiens_hsa05160 | -0.1461568 |
121 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1269333 |
122 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1062673 |
123 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0932784 |
124 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0807340 |
125 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0642115 |
126 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0358454 |